Remicade


Also found in: Thesaurus, Medical, Wikipedia.

Rem·i·cade

 (rĕm′ĭ-kād′)
A trademark for the drug infliximab.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Remicade - a monoclonal antibody (trade name Remicade) used to treat Crohn's disease and rheumatoid arthritis; administered by infusion; use and dosage must be determined by a physician
monoclonal, monoclonal antibody - any of a class of antibodies produced in the laboratory by a single clone of cells or a cell line and consisting of identical antibody molecules
2.Remicade - an anti-TNF compound (trade name Remicade) consisting of an antibody directed against TNF; it is given intravenously at one-month to three-month intervals; used in treatment of regional enteritis and rheumatoid arthritis
anti-TNF compound - a class of drugs that block the action of tumor necrosis factor (TNF); used in cases of rheumatoid arthritis because TNF instigates inflammation of the joints
brand, brand name, marque, trade name - a name given to a product or service
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
M2 EQUITYBITES-March 17, 2015-Samsung Bioepis submits marketing authorisation application for approval of Remicade
JOHNSON & JOHNSON, AS A RESULT OF THE PROPOSED MERGER between Schering-Plough and Merck, has initiated arbitration proceedings regarding its right to terminate the distribution agreement related to Schering-Plough's rights to Remicade and Simponi.
Revenue for the latest quarter rose to $4.7 billion from $3 billion as sales of the rheumatoid arthritis treatment Remicade increased 36% to $507 million and the allergy treatment Nasonex increased 8% to $307 million.
Meanwhile, Johnson & Johnson is boosting its sales operation to maintain its market-leading role for Remicade, an RA treatment that has been available since 1999.
M2 PHARMA-March 17, 2015-Samsung Bioepis submits marketing authorisation application for approval of Remicade
It has been developed as a biosimilar to the anti-inflammatory drug, Remicade, and is a powder for concentrate for solution for infusion supplied at 100mg infliximab per vial.
Comments: Sales of Remicade were $491 million in the quarter (+8%) and $2.1 billion for the year (+28%).
(Thousand Oaks CA) and Wyeth (Madison NJ), and Remicade, made by Johnson & Johnson (New Brunswick NJ) and Schering-Plough Corp.
The major European markets can finally benefit from the availability of Inflectra following the patent expiry of reference product Remicade (infliximab).
Ustekinumab, offered as an injectable alternative to J&J's own Remicade, may compete with Abbott Laboratories' Humira, Genentech Inc.'s Raptiva, and Amgen Inc.'s Enbrel.
According to the company, it will use the proceeds to support the commercialisation and clinical development of BOW015 (biosimilar to Remicade), initiate an additional Phase 3 clinical trial for BOW015 in Europe, support its ongoing development activities for BOW050 (biosimilar to Humira) and BOW030 (biosimilar to Avastin).